Treatment Registry
TR-0448 ActiveRecorded September 2, 2026Last verified September 3, 2026

Compounded tirzepatide

Sold by Vigormeds · Sublingual · every compounded tirzepatide record

What you actually pay

Per month

$159

Medication · Tirzepatide Sublingual, FIRST100 promo price$159

Added from the figures recorded below.

Price

TermPer monthCharged today
Tirzepatide Sublingual, FIRST100 promo price

$100 off from $159 per month Promocode: FIRST100 ● $100 off Tirzepatide Sublingual

source, read September 2, 2026

Per month$159Charged today$159
Visit Vigormeds

We earn nothing from this link. Vigormeds has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

  1. September 2, 2026$159
  2. September 3, 2026$159
  • September 2, 2026Entry added to the register

Sourcing and terms

PrescriberLive visit
Cancellation“If for any reason, you decide to cancel your membership subscription within 30 days from your initial enrollment, you are eligible for a full refund of your first month’s fee and you will lose access to your membership immediately.”
MembershipNot disclosed

Not yet checked: pharmacy, states and consult fee.

Recorded from vigormeds.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2, 2026The 'States We Serve' page (states-we-serve.html) renders only the heading 'States We Serve' four times with no actual state names in visible text — it appears to be a JS-driven map/legend ('Actively installing', 'Coming soon', 'Room to grow') that fetch_site.py cannot read; a state dropdown exists but it is a generic account-registration field listing all 50 states, not a coverage claim, so it was not used. All four listed prices are explicitly tagged 'FIRST100' promo pricing ($100 off); the non-promotional base price is not shown. 'Coming soon' items (Semaglutide/Tirzepatide Microdosing, Liraglutide, Naltrexone Capsules) are excluded as not yet available. The ToS describes a bundled 'Basic Membership' with no separately stated fee, so membership.found is false rather than a positive membership charge.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0448
Readings
2

Related records

What else Vigormeds sells

All Vigormeds programs and terms

Compounded tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 307 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Vigormeds compounded tirzepatide (TR-0448). Last verified September 3, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0448

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.